Breaking News Instant updates and real-time market news.

OMCL

Omnicell

$69.70

0.66 (0.96%)

04:55
11/07/18
11/07
04:55
11/07/18
04:55

Omnicell management to meet with JPMorgan

Meetings to be held in Boston on November 6 and in New York on November 7 hosted by JPMorgan.

  • 07

    Nov

  • 27

    Nov

OMCL Omnicell
$69.70

0.66 (0.96%)

09/17/18
CHLM
09/17/18
NO CHANGE
Target $80
CHLM
Buy
Omnicell price target raised to $80 from $65 at Craig-Hallum
Craig-Hallum analyst Matt Hewitt reiterated a Buy rating on Omnicell and raised his price target to $80 from $65 following the results of a recent industry survey. In a research note to investors, Hewitt says he was encouraged to see that Omnicell was the leading vendor of automated dispensing cabinets amongst customers surveyed in Pharmacy Purchasing & Products' annual State of Pharmacy Automation survey, with 49% using its cabinets vs. 37% last year, demonstrating that the launch of the XT is helping the company continue to take share from competitors. Hewitt notes that the survey indicates Omnicell is at or near the top of the list for many of its product categories where hospitals are considering buying over the next few years. Given the strong trends across multiple product categories for Omnicell, Hewitt sees the potential for accelerating growth in both bookings and product revenue, especially as newer products like the XR2 and IVX gain meaningful traction.
10/05/18
BNCH
10/05/18
NO CHANGE
Target $79
BNCH
Buy
Omnicell price target raised to $79 after product launches at Benchmark
Benchmark analyst Bill Sutherland said Omnicell appears to be entering a multi-year period of above-average growth and expanding margins following the recent launch of several products. He expects bookings momentum to continue to build and thinks margin growth could exceed current 2019-2020 consensus, Sutherland added. He raised his price target on Omnicell shares to $79 from $66 and keeps a Buy rating on the stock.
10/22/18
OPCO
10/22/18
NO CHANGE
Target $71
OPCO
Outperform
Omnicell price target raised to $71 from $59 at Oppenheimer
Oppenheimer analyst Mohan Naidu raised his price target for Omnicell (OMCL) to $71 from $59 as his channel checks ahead of Q3 show consistent market share gains in cabinets and steady XT feedback from customers. The analyst expects an in-line Q3, but the timing of XR2 release and implementation could provide upside to Q4. While the core business continues to execute well, investors' attention is slowly shifting toward the MedAdherence segment after Amazon's (AMZN) acquisition of PillPack, but Naidu cautions that numbers upside could be limited from that segment in the near-term. He reiterates an Outperform rating on Omnicell shares.
10/26/18
CANT
10/26/18
NO CHANGE
Target $70
CANT
Overweight
Omnicell price target raised to $70 from $63 at Cantor Fitzgerald
Cantor Fitzgerald analyst Steven Halper raised his price target for Omnicell to $70 and reiterates an Overweight rating on the shares following the company's Q3 results. The analyst remain bullish on Omnicell's long-term growth outlook and believes it fundamentals are improving.

TODAY'S FREE FLY STORIES

STG

Sunlands Online

$5.10

0.09 (1.80%)

08:56
02/19/19
02/19
08:56
02/19/19
08:56
Downgrade
Sunlands Online rating change  »

Sunlands Online…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:55
02/19/19
02/19
08:55
02/19/19
08:55
Conference/Events
UBS alternative energy analyst to hold an analyst/industry conference call »

Alternative Energy…

DE

Deere

$158.99

-3.45 (-2.12%)

08:55
02/19/19
02/19
08:55
02/19/19
08:55
Downgrade
Deere rating change  »

Deere downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 27

    Feb

MLCO

Melco Resorts & Entertainment

$21.76

0.35 (1.63%)

08:55
02/19/19
02/19
08:55
02/19/19
08:55
Upgrade
Melco Resorts & Entertainment rating change  »

Melco Resorts &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$29.11

0.73 (2.57%)

, LLY

Eli Lilly

$122.46

1.77 (1.47%)

08:55
02/19/19
02/19
08:55
02/19/19
08:55
Options
Notable open interest changes for February 19th »

Friday's total…

BAC

Bank of America

$29.11

0.73 (2.57%)

LLY

Eli Lilly

$122.46

1.77 (1.47%)

GE

General Electric

$10.09

0.055 (0.55%)

EBAY

eBay

$36.59

0.28 (0.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 03

    Mar

  • 18

    May

KCAP

KCAP Financial

$3.52

-0.03 (-0.85%)

08:55
02/19/19
02/19
08:55
02/19/19
08:55
Conference/Events
KCAP Financial to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

ALV

Autoliv

$78.22

1.97 (2.58%)

08:54
02/19/19
02/19
08:54
02/19/19
08:54
Upgrade
Autoliv rating change  »

Autoliv upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

AEE

Ameren

$69.67

0.64 (0.93%)

08:54
02/19/19
02/19
08:54
02/19/19
08:54
Conference/Events
Ameren management to meet with Morgan Stanley »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

  • 04

    Mar

08:50
02/19/19
02/19
08:50
02/19/19
08:50
Conference/Events
Cowen Washington research group to hold a meeting »

Cowen's Washington…

ECL

Ecolab

$163.45

1.82 (1.13%)

08:50
02/19/19
02/19
08:50
02/19/19
08:50
Earnings
Ecolab sees FY19 adj. EPS $5.80-$6.00, consensus $5.91 »

The outlook provided…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 20

    Feb

  • 11

    Mar

  • 11

    Mar

  • 12

    Mar

  • 13

    Mar

  • 14

    Mar

  • 20

    Mar

  • 21

    Mar

  • 22

    Mar

  • 28

    May

CRUS

Cirrus Logic

$40.00

0.85 (2.17%)

08:48
02/19/19
02/19
08:48
02/19/19
08:48
Conference/Events
Cirrus Logic management to meet with Cowen »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 20

    Feb

  • 21

    Feb

ECL

Ecolab

$163.45

1.82 (1.13%)

08:47
02/19/19
02/19
08:47
02/19/19
08:47
Earnings
Ecolab reports Q4 adj. EPS $1.54, consensus $1.54 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 20

    Feb

  • 11

    Mar

  • 11

    Mar

  • 12

    Mar

  • 13

    Mar

  • 14

    Mar

  • 20

    Mar

  • 21

    Mar

  • 22

    Mar

  • 28

    May

ORTX

Orchard Therapeutics

$15.08

0.58 (4.00%)

08:47
02/19/19
02/19
08:47
02/19/19
08:47
Conference/Events
Orchard Therapeutics management to meet with Cowen »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 20

    Feb

GSK

GlaxoSmithKline

$41.24

0.38 (0.93%)

08:46
02/19/19
02/19
08:46
02/19/19
08:46
Conference/Events
GlaxoSmithKline management to meet with Cowen »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 18

    May

GMDA

Gamida Cell

$13.25

0.3 (2.32%)

, EDIT

Editas Medicine

$20.09

0.22 (1.11%)

08:45
02/19/19
02/19
08:45
02/19/19
08:45
Hot Stocks
Gamida Cell, Editas Medicine announce agreement to evaluate use of CRISPR tech »

Gamida Cell (GMDA)…

GMDA

Gamida Cell

$13.25

0.3 (2.32%)

EDIT

Editas Medicine

$20.09

0.22 (1.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

EXPD

Expeditors

$73.56

-0.45 (-0.61%)

08:45
02/19/19
02/19
08:45
02/19/19
08:45
Earnings
Expeditors reports Q4 EPS $1.02, consensus 85c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MPO

Midstates Petroleum

$9.25

-0.17 (-1.80%)

, AXDX

Accelerate Diagnostics

$19.82

0.65 (3.39%)

08:45
02/19/19
02/19
08:45
02/19/19
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

MPO

Midstates Petroleum

$9.25

-0.17 (-1.80%)

AXDX

Accelerate Diagnostics

$19.82

0.65 (3.39%)

WATT

Energous

$8.91

0.11 (1.25%)

CRON

Cronos Group

$21.28

0.46 (2.21%)

NIO

NIO Inc.

$7.41

-0.07 (-0.94%)

EPD

Enterprise Products

$28.21

0.01 (0.04%)

NBEV

New Age Beverages

$6.50

-0.08 (-1.22%)

ITB

iShares U.S. Home Construction ETF

$35.22

0.36 (1.03%)

CWH

Camping World

$15.11

-0.105 (-0.69%)

SAND

Sandstorm Gold

$5.49

0.06 (1.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 21

    Feb

  • 22

    Feb

  • 27

    Feb

  • 04

    Mar

WBC

Wabco

$116.78

0.19 (0.16%)

08:44
02/19/19
02/19
08:44
02/19/19
08:44
Recommendations
Wabco analyst commentary  »

Baird would be aggressive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADVM

Adverum Biotechnologies

$3.80

0.28 (7.95%)

08:43
02/19/19
02/19
08:43
02/19/19
08:43
Conference/Events
Adverum Biotechnologies management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

  • 22

    Feb

  • 27

    Feb

DPZ

Domino's Pizza

$281.63

-5.46 (-1.90%)

08:43
02/19/19
02/19
08:43
02/19/19
08:43
Recommendations
Domino's Pizza analyst commentary  »

Domino's Pizza price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

  • 14

    Mar

08:42
02/19/19
02/19
08:42
02/19/19
08:42
Conference/Events
UBS pharmaceuticals analyst to hold an analyst/industry conference call »

Pharmaceuticals Analyst…

GVA

Granite Construction

$45.48

0.59 (1.31%)

08:42
02/19/19
02/19
08:42
02/19/19
08:42
Hot Stocks
Granite's Water and Mineral Services Group awarded $22.5M in sewer projects »

Granite announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

WWW

Wolverine World Wide

$39.54

0.94 (2.44%)

08:42
02/19/19
02/19
08:42
02/19/19
08:42
Recommendations
Wolverine World Wide analyst commentary  »

Fresh Pick designation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

MCEP

Mid-Con Energy

$0.98

0.06 (6.52%)

08:41
02/19/19
02/19
08:41
02/19/19
08:41
Hot Stocks
Mid-Con Energy sell Texas properties for $60M, buys Oklahoma assets for $27.5M »

Mid-Con Energy, through…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KTOS

Kratos Defense

$16.95

(0.00%)

08:41
02/19/19
02/19
08:41
02/19/19
08:41
Recommendations
Kratos Defense analyst commentary  »

Kratos Defense price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.